Your search returned 22 results.

Sort
Results
1.
Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31271271
Year: 2019
Citation:
  • The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Giovanella L, van Nostrand D
2.
Should patients with papillary microcarcinoma undergo radioiodine ablation?. MedStar authors:
  • Wartofsky, Leonard
PMID:
  • 23817838
Year: 2013
Citation:
  • Endocrine. 44(2):278-9, 2013 Oct.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Wartofsky L
3.
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Ylli, Dorina
PMID:
  • 30717901
Year: 2019
Citation:
  • Endocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D, Wartofsky L, Ylli D
4.
SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 35649660
Year: 2022
Citation:
  • Journal of Nuclear Medicine. 63(6):15N-35N, 2022 Jun.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Avram AM, Giovanella L, Greenspan B, Lawson SA, Luster M, Ovcaricek PP, Peacock JG, Silberstein E, Tulchinsky M, Van Nostrand D, Verburg FA, Vrachimis A
5.
Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors:
  • Bethancourt, Evelyn
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30361377
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(5):638-643, 2019 05.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D
6.
Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160436
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
7.
Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30105931
Year: 2018
Citation:
  • Thyroid. 28(9):1083-1093, 2018 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
8.
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 31451488
Year: 2020
Citation:
  • Journal of Nuclear Medicine. 61(3):397-404, 2020 03.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bloom G, Burman KD, Gomes-Lima CJ, Van Nostrand D, Wartofsky L, Wu D
9.
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30900516
Year: 2019
Citation:
  • Thyroid. 29(4):461-470, 2019 04.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA
10.
Effects of Dosimetrically Guided I-131 Therapy on Hematopoiesis in Patients With Differentiated Thyroid Cancer. MedStar authors:
  • Atkins, Francis
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Desale, Sameer
  • Mete, Mihriye
  • Schneider, Mark
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 26900639
Year: 2016
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 101(4):1762-9, 2016 Apr
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Bikas A, Burman KD, Desale S, Mete M, Schneider M, Van Nostrand D, Wartofsky L
11.
Clinical, Pathological, and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. MedStar authors:
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Jonklaas, Jacqueline
  • Shobab, Leila
  • Wartofsky, Leonard
  • Zeymo, Alexander
PMID:
  • 31319763
Year: 2019
Citation:
  • Thyroid. 29(9):1262-1268, 2019 09.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Feldman R, Gomes-Lima CJ, Jonklaas J, Shobab L, Wartofsky L, Zeymo A
12.
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors:
  • Garcia, Carlos
  • Plyku, Donika
  • Van Nostrand, Douglas
  • Wu, Di
PMID:
  • 35119623
Year: 2022
Citation:
  • Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D
13.
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 26357962
Year: 2015
Citation:
  • Thyroid. 25(12):1347-50, 2015 Dec.
Institution:
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Validation Studies
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L
14.
Poor patient compliance with instructions for continuous sialogogues after <sup>131</sup> I therapy. MedStar authors:
  • Burman, Kenneth D
  • Kulkarni, Kanchan
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30169900
Year: 2019
Citation:
  • Oral Diseases. 25(1):158-163, 2019 Jan.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Kharazi P, Khorjekar G, Kulkarni K, Moreau S, Van Nostrand D, Wartofsky L, Wu D
15.
Management of recurrent cervical papillary thyroid cancer. [Review] MedStar authors:
  • Burman, Kenneth D
  • Goyal, Rachna M
  • Jonklaas, Jacqueline
PMID:
  • 24891178
Citation:
  • Endocrinology & Metabolism Clinics of North America. 43(2):565-72, 2014 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Goyal RM, Jonklaas J
16.
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth
  • Garcia, Carlos
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Orquiza, Michael H
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 24820222
Citation:
  • Thyroid. 24(9):1394-9, 2014 Sep.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L
17.
Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer<:/ovid:b>: . MedStar authors:
  • Wartofsky, Leonard
PMID:
  • 31964314
Year: 2020
Citation:
  • Thyroid. 30(5):653-660, 2020 05.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bober B, Kaminski G, Kapusta W, Kowalski L, Lubas A, Niemczyk S, Saracyn M, Wartofsky L
18.
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22313411
Citation:
  • Thyroid. 22(3):310-7, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L
19.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Francis
  • Garcia, Carlos
  • Van Nostrand, Douglas
PMID:
  • 28104741
Year: 2017
Citation:
  • Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
20.
Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?. MedStar authors:
  • Atkins, Francis
  • Kulkarni, Kanchan
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wexler, Jason
PMID:
  • 24177041
Citation:
  • Nuclear Medicine Communications. 35(2):210-6, 2014 Feb.
Medline publication type:
  • Clinical Trial
  • Comparative Study
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Kulkarni K, Mete M, Van Nostrand D, Wartofsky L, Wexler J
21.
Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 29650270
Year: 2018
Citation:
  • Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D
22.
Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?. MedStar authors:
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Gomes-Lima, Cristiane J
  • Lee, Wen
  • Shobab, Leila
  • Wartofsky, Leonard
  • Wu, Di
  • Ylli, Dorina
PMID:
  • 33716974
Year: 2021
Citation:
  • Frontiers in Endocrinology. 12:623182, 2021.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Pathology
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Bikas A, Burman KD, Castro LC, Feldman R, Gomes-Lima CJ, Jensen K, Jonklaas J, Lee W, McCoy M, Rao SN, Shobab L, Vasko V, Wartofsky L, Wu D, Ylli D
Pages

Powered by Koha